Barely Significant
← all phrases

“a slight trend”

4,079 sentences · 4,079 papers · 4,917 search hits before verification · confirmed specimen

Sighted at

p<0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

Overall, there was a slight trend that survival rate was higher in patients who received T-DXd treatment ≤2/>2 months after nivolumab therapy (HR [95% CI]: 0.79 [0.53–1.17]) compared with those who received T-DXd treatment ≤3/>3 months (HR [95% CI]: 0.87 [0.58–1.30]), ≤4/>4 months (HR [95% CI]: 0.97 [0.65–1.46]), and ≤5/>5 months (HR [95% CI]: 0.93 [0.62–1.40]) after nivolumab therapy ( Fig.
Clinical trial findings on the OpHLINE ® series confirmed a favourable safety profile across all formulations The overall safety profile was favourable across all formulations although a slight trend of a concentration-dependent IOP spike trade-off was detected.